Psoriatic Arthritis: An Update
Open Access
- 13 November 2012
- journal article
- review article
- Published by Hindawi Limited in Arthritis
- Vol. 2012, 1-6
Abstract
Psoriatic arthritis is a debilitating condition, which affects approximately one-quarter of psoriasis patients. Recent findings have furthered our understanding of the complex pathophysiology of PsA. There have been major advances in the identification of genes associated with joint involvement but not with cutaneous disease alone. The elucidation of key immunologic pathways has allowed the development of novel targeted therapies that are in the research pipeline. Currently, good screening tests and biomarkers to diagnose early PsA and to guide therapy are limited. In this paper, we present recent findings with regard to the immunopathogenesis and genetics of PsA, biomarkers, and screening tools and review the targeted therapies currently in clinical trials.Keywords
This publication has 35 references indexed in Scilit:
- Evidence to support IL-13 as a risk locus for psoriatic arthritis but not psoriasis vulgarisAnnals of the Rheumatic Diseases, 2011
- NF-κB in immunobiologyCell Research, 2011
- Genome-wide association analysis identifies three psoriasis susceptibility lociNature Genetics, 2010
- Genome-wide association study identifies a psoriasis susceptibility locus at TRAF3IP2Nature Genetics, 2010
- Efficacy and safety of anti-TNF therapies in psoriatic arthritis: an observational study from the British Society for Rheumatology Biologics RegisterRheumatology, 2010
- Regulation of NF-κB by NSD1/FBXL11-dependent reversible lysine methylation of p65Proceedings of the National Academy of Sciences, 2009
- Genome-wide scan reveals association of psoriasis with IL-23 and NF-κB pathwaysNature Genetics, 2009
- Detailed analysis of the cell infiltrate and the expression of mediators of synovial inflammation and joint destruction in the synovium of patients with psoriatic arthritis: implications for treatmentAnnals of the Rheumatic Diseases, 2006
- Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasisArchives of Dermatological Research, 2006
- Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptidesJournal of Experimental Medicine, 2006